| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Kenney Christopher John is a Chief Medical Officer at Xenon Pharmaceuticals Inc.. Recent SEC Form 4 filings include 1 buy and 3 sells.
Estimated insider holdings value: $402K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 13, 2026 | XENE Xenon Pharmaceuticals Inc. | Chief Medical Officer | Sale+OE | 1,410 | $55.23 | $77,867.25 | -16.6% | - | - | |
| Mar 10, 2026 | XENE Xenon Pharmaceuticals Inc. | Chief Medical Officer | Sale+OE | 2,771 | $60.11 | $166,559.27 | -36.9% | - | - | |
| Mar 24, 2023 | XENE Xenon Pharmaceuticals Inc. | Chief Medical Officer | Sell | 700 | $35.01 | $24,507.00 | -100% | +16.0% | +25.5% | |
| Jan 21, 2022 | XENE Xenon Pharmaceuticals Inc. | Chief Medical Officer | Buy | 700 | $28.81 | $20,167.00 | New | +25.8% | +40.3% |